<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89885">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01934920</url>
  </required_header>
  <id_info>
    <org_study_id>Elman-01</org_study_id>
    <nct_id>NCT01934920</nct_id>
  </id_info>
  <brief_title>Identifying Patients With Unrecognized Treatable Diabetic Macular Edema</brief_title>
  <official_title>Identifying Patients With Unrecognized Treatable Diabetic Macular Edema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elman Retina Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Genentech, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Elman Retina Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME)
      in diabetic patients that undergo a DME screening exam. The screening exam will consist of
      medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus
      photography
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the incidence of new and/or undiagnosed diabetic macular edema.</measure>
    <time_frame>1 day (Patients are only seen once for assessments)</time_frame>
    <description>This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Streamlining and identification of patients at risk of diabetic macular edema</measure>
    <time_frame>1 day (Patients only seen once for assessments)</time_frame>
    <description>Establish methods for streamlining screening and identification of patients at risk.
Establish methods for referral for treatment of patients identified with vision threatening diabetic retinopathy.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Diabetic Macular Edema</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients identified through medical records or admitted into Franklin Square Hospital with
        a history of diabetes
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to provide written informed consent and comply with study assessments for the
             full duration of the study

          -  Age &gt; 18 years

          -  Patient related considerations

          -  Patients with diabetes mellitus

          -  Disease related considerations

          -  Diabetes mellitus

        Exclusion Criteria:

          -  Prior admission screening within twelve months.

          -  Inability to sit for evaluation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Elman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Elman Retina Group, P.A.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jill Nuss</last_name>
    <phone>410-686-3000</phone>
    <email>nuss@elmanretina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer L Belz</last_name>
    <phone>410-686-3000</phone>
    <email>belz@elmanretina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Franklin Square Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michael J Elman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 5, 2016</lastchanged_date>
  <firstreceived_date>August 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
